-glutide
A GLP-1 analogue: a version of the gut hormone that raises insulin after meals and slows the stomach. Used in type 2 diabetes and obesity.
- Drugs ending in -glutide: 11
- Approved somewhere: 5
- With a US drug page: 5
- Stem
- -glutide
- Class
- GLP-1 analogues, which lower blood sugar and appetite
- Sub-stem of
- -tide: Peptides
Approved and clinical-stage drugs in ChEMBL whose names ending in -glutide, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Albiglutide | Approved | GLP1R | Glucagon-like peptide 1 receptor agonist |
| Dulaglutide | Approved | GLP1R | Glucagon-like peptide 1 receptor agonist |
| Liraglutide | Approved | GLP1R | Glucagon-like peptide 1 receptor agonist |
| Semaglutide | Approved | GLP1R | Glucagon-like peptide 1 receptor agonist |
| Teduglutide | Approved | GLP2R | Glucagon-like peptide 2 receptor agonist |
| Ecnoglutide | Phase 3 | — | — |
| Glepaglutide | Phase 3 | — | — |
| Taspoglutide | Phase 3 | GLP1R | Glucagon-like peptide 1 receptor agonist |
| Elsiglutide | Phase 2 | GLP2R | Glucagon-like peptide 2 receptor agonist |
| Froniglutide | Phase 2 | — | — |
| Beinaglutide | — | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO